CK-586, identified by its CAS number 2830607-59-3, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category are often evaluated for their efficacy, safety, and mechanism of action. Typically, such substances may exhibit properties like selective binding to certain biological targets, which can influence cellular pathways. Additionally, they may undergo various forms of testing to assess their pharmacokinetics and pharmacodynamics. As with many investigational compounds, detailed information regarding CK-586's characteristics, including its synthesis, stability, and biological activity, is usually found in specialized scientific literature or databases. Researchers often focus on its potential benefits in treating specific conditions, alongside any associated side effects or interactions with other drugs. For the most accurate and comprehensive details, consulting peer-reviewed studies or chemical databases is recommended.

CK-586

2830607-59-3: CK-586, identified by its CAS number 2830607-59-3, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category are often evaluated for their efficacy, safety, and mechanism of action. Typically, such substances may exhibit properties like selective binding to certain biological targets, which can influence cellular pathways. Additionally, they may undergo various forms of testing to assess their pharmacokinetics and pharmacodynamics. As with many investigational compounds, detailed information regarding CK-586's characteristics, including its synthesis, stability, and biological activity, is usually found in specialized scientific literature or databases. Researchers often focus on its potential benefits in treating specific conditions, alongside any associated side effects or interactions with other drugs. For the most accurate and comprehensive details, consulting peer-reviewed studies or chemical databases is recommended.

5-(3,4-Difluorobenzyl)-8-(trans-4-methylcyclohexyl)-6,9-dioxo-2,5,8-triazaspiro[3.5]nonane-2-carbaldehyde

Ulacamten is an effective inhibitor of cardiac myosin (cardiacmyosin).

CAS 2830607-59-3

CK-586

5-(3,4-Difluorobenzyl)-8-(trans-4-methylcyclohexyl)-6,9-dioxo-2,5,8-triazaspiro[3.5]nonane-2-carbaldehyde

Ref: 54-PC1007960

Ulacamten

Ref: TM-T201288